Dr Reddy's Laboratories Ltd (STU:RDDA)

€ 13.3 -0.2 (-1.48%) Market Cap: 11.08 Bil Enterprise Value: 10.96 Bil PE Ratio: 23.15 PB Ratio: 3.28 GF Score: 90/100

Half Year 2025 Dr Reddy's Laboratories Ltd Earnings Call Transcript
Nov 05, 2024

€13.3 (-1.48%)

Earnings
Q1 2025 Dr Reddy's Laboratories Ltd Earnings Call Transcript
Jul 27, 2024

Earnings
Dr Reddy's Laboratories Ltd to Discuss Acquisition of Nicotinell Call Transcript
Jun 26, 2024
Q4 2024 Dr Reddy's Laboratories Ltd Earnings Call Transcript
May 07, 2024

€13.4 (-2.90%)

Earnings
Q3 2024 Dr Reddy's Laboratories Ltd Earnings Call Transcript
Jan 30, 2024

€12.7 (-0.78%)

Earnings
Half Year 2024 Dr Reddy's Laboratories Ltd Earnings Call Transcript
Oct 27, 2023

€12.2 (-0.81%)

Earnings
Q1 2024 Dr Reddy's Laboratories Ltd Earnings Call Transcript
Jul 26, 2023

€12 (+0.84%)

Earnings
Q4 2023 Dr Reddy's Laboratories Ltd Earnings Call Transcript
May 10, 2023

€11 (+0.92%)

Earnings
Eris Lifesciences Ltd to Announce Acquisition of Nine Dermatology Brands From Dr Reddy's Laboratories Ltd Call Transcript
Mar 16, 2023
Q3 2023 Dr Reddy's Laboratories Ltd Earnings Call Transcript
Jan 25, 2023

€9.44 (-1.67%)

Earnings
Q2 2023 Dr Reddy's Laboratories Ltd Earnings Call Transcript
Oct 28, 2022

€10.8

Earnings
Q1 2023 Dr Reddy's Laboratories Ltd Earnings Call Transcript
Jul 28, 2022

€10.5

Earnings
Dr Reddy's Laboratories Ltd Investor Day Transcript
Jun 21, 2022
Q4 2022 Dr Reddy's Laboratories Ltd Earnings Call Transcript
May 19, 2022

€9.48 (-0.84%)

Earnings
Q3 2022 Dr Reddy's Laboratories Ltd Earnings Call Transcript
Jan 28, 2022

€9.64 (-4.55%)

Earnings
Q2 2022 Dr Reddy's Laboratories Ltd Earnings Call Transcript
Oct 29, 2021

€10.6 (+1.92%)

Earnings
Q1 2022 Dr Reddy's Laboratories Ltd Earnings Call Transcript
Jul 27, 2021

€12.2

Earnings
Q4 2021 Dr.Reddy's Laboratories Ltd Earnings Call Transcript
May 14, 2021

€11.7 (-1.68%)

Earnings
Q3 2021 Dr.Reddy's Laboratories Ltd Earnings Call Transcript
Jan 29, 2021

€10.2 (-5.56%)

Earnings
Dr.Reddy's Laboratories Ltd at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 13, 2021
Q2 2021 Dr.Reddy's Laboratories Ltd Earnings Call Transcript
Oct 28, 2020

€11.3 (-2.59%)

Earnings
Q1 2021 Dr.Reddy's Laboratories Ltd Earnings Call Transcript
Jul 29, 2020

€9.84 (+6.03%)

Earnings
Q4 2020 Dr.Reddy's Laboratories Ltd Earnings Call Transcript
May 20, 2020

€9.44 (+5.83%)

Earnings
Q3 2020 Dr.Reddy's Laboratories Ltd Earnings Call Transcript
Jan 27, 2020

€7.96 (+4.74%)

Earnings
Dr.Reddy's Laboratories Ltd at JPMorgan Healthcare Conference Transcript
Jan 14, 2020
Q2 2020 Dr.Reddy's Laboratories Ltd Earnings Call Transcript
Nov 01, 2019

€7.08 (+1.14%)

Earnings
Q1 2020 Dr.Reddy's Laboratories Ltd Earnings Call Transcript
Jul 29, 2019

€6.65 (-5.03%)

Earnings
Q4 2019 Dr.Reddy's Laboratories Ltd Earnings Call Transcript
May 17, 2019

€6.88 (-3.91%)

Earnings

Dr.Reddy's Laboratories Ltd at JPMorgan Healthcare Conference Transcript

Jan 14, 2020 / 09:30PM GMT

Release Date Price: €7.44 (+0.54%)

Transcript

Neha Manpuria

JP Morgan Chase & Co, Research Division - Analyst

Good afternoon, everyone. I am Neha Manpuria, JPMorgan's India pharmaceutical and health care services analyst. Welcome to the JPMorgan Healthcare Conference Emerging Market Track. Thank you for being here. We'll start off the present -- India Track with Dr. Reddy's. We have Mr. Erez Israeli, the CEO of the company, presenting to us today. Over to you, sir.

Erez Israeli;s Laboratories Limited;CEO;Member of the Management Council

Dr. Reddy

'-&

So thank you, Neha. Thank you all. Thanks for all the people for coming. We know that we have the after lunch slot. It's not always easy. So we appreciate all the people that made the effort and came to see our presentations. We are competing against lunch and against a beautiful view outside, and we'll do our best to share with you our story and hope that you like it as well.

And before we start, also another wish, happy New Year for all of you and your families wherever you are.

So

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.